Tirzapatide

Tirzepatide is a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This means it mimics the actions of these two gut

IUPAC name:

CAS No.

2023788-19-2

Molecular Weight:

4813.527g.mol−1

Molecular Formula:

C225H348N48O68

Granule:

Mechanism Of Action :

Tirzepatide is a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This means it mimics the actions of these two gut hormones. When injected, tirzepatide stimulates the pancreas to release insulin in response to food intake and reduces the amount of glucose produced by the liver. This dual action helps to lower blood glucose levels and improve glycemic control in people with type 2 diabetes.

Indications :

type 2 diabetes

Tirzepatide is indicated for use in adults with type 2 diabetes to improve glycemic control as an adjunct to diet and exercise.

Chronic weight management

Additionally, it is used for chronic weight management in adults who are obese or overweight with at least one weight-related comorbid condition, such as hypertension, dyslipidemia, or cardiovascular disease. It is administered as a once-weekly subcutaneous injection.

information

Category: Anti-Diabetic

September 6, 2024

Desloratadine

Anti-Histamine

Cas No: 100643-71-8

Mechanism Of Action: Desloratadine is a non-sedating, long-acting antihistamine that selectively blocks peripheral histamine H1-receptors. It is the major active metabolite of loratadine and works

Voriconazole

Anti-Microbial

Cas No: 137234-62-9

Mechanism Of Action: Voriconazole is a triazole antifungal agent that works by inhibiting the fungal cytochrome P450 enzyme 14-alpha-lanosterol demethylase1. This enzyme is crucial for

Enoxaparin Sodium

Cardiovascular

Cas No: 679809-58-6

Mechanism Of Action: Enoxaparin, a low molecular weight heparin (LMWH), works primarily by activating antithrombin III, which in turn inhibits factor Xa and IIa (thrombin).

Tirzapatide

Anti-Diabetic

Cas No: 2023788-19-2

Mechanism Of Action : Tirzepatide is a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This means it mimics the

Lenvatinib Mesylate

Oncology

Cas No: 857890-39-2

Mechanism Of Action: Lenvatinib is classified as a receptor tyrosine kinase (RTK) inhibitor that effectively suppresses the kinase activities of vascular endothelial growth factor (VEGF)

TRAMETINIB DIMETHYL SULFOXIDE

Oncology

Cas No: 1187431-43-1

Mechanism Of Action: Trametinib is identified as a reversible and remarkably selective allosteric inhibitor of MEK1 and MEK2. Through its high-affinity binding to unphosphorylated MEK1